# Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.

Study · id `cardio:ct-nct02809131` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02809131](<https://clinicaltrials.gov/study/NCT02809131>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02809131

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1010 participants.

## Technical summary

Registry record NCT02809131. Randomized; no masking; primary purpose prevention. Start 2016-04-01 (actual); primary completion 2021-03-31 (actual). Results posted on 2022-05-09.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1010 participants (enrolled count; ClinicalTrials.gov record NCT02809131, source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)
- Started: 2016-04-01 (actual) (ClinicalTrials.gov record NCT02809131, source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)
- Primary completion: 2021-03-31 (actual) (ClinicalTrials.gov record NCT02809131, source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)
- Completion: 2021-09-30 (actual) (ClinicalTrials.gov record NCT02809131, source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)
- Results first posted: 2022-05-09 (ClinicalTrials.gov record NCT02809131, source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT02809131, source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02809131-2022-05-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
- Acronym: ENVELOPE
- Condition: Sick Sinus Syndrome
- Condition: Complete Heart Block
- Condition: Syncope
- Condition: Chronic Systolic Heart Failure
- Intervention (Drug): polymixin/bacitracin
- Intervention (Drug): cephalexin, or levofloxacin, or clindamycin
- Intervention (Drug): Saline
- Lead sponsor: Vanderbilt University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Thomas Jefferson University
- Collaborator class: OTHER
- Collaborator: Cooper Norcross Health
- Collaborator class: OTHER
- Collaborator: Valley Health System
- Collaborator class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry condition terms include this condition: Sick sinus syndrome (`cardio:sick-sinus-syndrome`)
- Registry lists this organization as the lead sponsor: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)
- Registry lists this organization as a collaborator: Thomas Jefferson University (`cardio:org-thomas-jefferson-university`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients (`cardio:pubmed-36960716`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9af3b1445865ad0bcbc6327d2802fa8622b638be29e79be68718e211b82963f8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
